Literature DB >> 24684796

Heritability and genetic association analysis of cognition in the Diabetes Heart Study.

Amanda J Cox1, Christina E Hugenschmidt2, Laura M Raffield3, Carl D Langefeld4, Barry I Freedman5, Jeff D Williamson2, Fang-Chi Hsu4, Donald W Bowden6.   

Abstract

Cognitive performance is an important component of healthy aging. Type 2 diabetes (T2D) is associated with negative outcomes for the brain and cognition, although causal mechanisms have not been definitely determined. Genetic risk factors warrant further consideration in this context. This study examined the heritability of cognitive function as assessed by (1) the Digit Symbol Substitution Task; (2) the Modified Mini-Mental State Examination; (3) the Stroop Task; (4) the Rey Auditory-Verbal Learning Task; and (5) the Controlled Oral Word Association Task for Phonemic and Semantic Fluency, in the family-based, T2D-enriched, Diabetes Heart Study sample (n = 550 participants from 257 families). The genetic basis of these cognitive measures was further evaluated by association analysis with candidate single-nucleotide polymorphisms (SNPs) and genome-wide SNP data. Measures of cognitive function were significantly heritable (hˆ(2) = 0.28-0.62) following adjustment for age, gender, and education. A total of 31 SNPs (from 26 genes/regions) selected to form an a priori set of candidate SNPs showed limited evidence of association with cognitive function when applying conservative metrics of significance. Genome-wide assessment of both noncoding and coding variants revealed suggestive evidence of association for several coding variants including rs139509083 in CNST (p = 4.9 × 10(-9)), rs199968569 in PLAA (p = 4.9 × 10(-9)) and rs138487371 in PCDH8 (p = 3.7 × 10(-8)). The identification of a heritable component to cognitive performance in T2D suggests a role for genetic contributors to cognitive performance even in the presence of metabolic disease and other associated comorbidities and is supported by the identification of genetic association signals in functionally plausible candidates.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Cognitive function; Genetics; Heritability; Type 2 diabetes

Mesh:

Year:  2014        PMID: 24684796      PMCID: PMC4418030          DOI: 10.1016/j.neurobiolaging.2014.03.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  48 in total

1.  A striking organization of a large family of human neural cadherin-like cell adhesion genes.

Authors:  Q Wu; T Maniatis
Journal:  Cell       Date:  1999-06-11       Impact factor: 41.582

2.  Diabetes mellitus and the risk of dementia: The Rotterdam Study.

Authors:  A Ott; R P Stolk; F van Harskamp; H A Pols; A Hofman; M M Breteler
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

Review 3.  The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.

Authors:  Nesrine Awad; Michèle Gagnon; Claude Messier
Journal:  J Clin Exp Neuropsychol       Date:  2004-11       Impact factor: 2.475

4.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

Authors:  Rita Peila; Beatriz L Rodriguez; Lenore J Launer
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

5.  The Modified Mini-Mental State (3MS) examination.

Authors:  E L Teng; H C Chui
Journal:  J Clin Psychiatry       Date:  1987-08       Impact factor: 4.384

6.  Stroop interference: aging effects assessed with the Stroop Color-Word Test.

Authors:  P J Houx; J Jolles; F W Vreeling
Journal:  Exp Aging Res       Date:  1993 Jul-Sep       Impact factor: 1.645

7.  CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.

Authors:  Patricia M Thompson; Takahiro Gotoh; Marleen Kok; Peter S White; Garrett M Brodeur
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

8.  A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus.

Authors:  Augustina M A Brands; Esther Van den Berg; Sanne M Manschot; Geert Jan Biessels; L Jaap Kappelle; Edward H F De Haan; Roy P C Kessels
Journal:  J Int Neuropsychol Soc       Date:  2007-03       Impact factor: 2.892

9.  Isolation and characterization of human and mouse WDR19,a novel WD-repeat protein exhibiting androgen-regulated expression in prostate epithelium.

Authors:  Biaoyang Lin; James T White; Angelita G Utleg; Shunyou Wang; Camari Ferguson; Lawrence D True; Robert Vessella; Leroy Hood; Peter S Nelson
Journal:  Genomics       Date:  2003-09       Impact factor: 5.736

10.  High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  14 in total

1.  Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes.

Authors:  Laura M Raffield; Gretchen A Brenes; Amanda J Cox; Barry I Freedman; Christina E Hugenschmidt; Fang-Chi Hsu; Jianzhao Xu; Benjamin C Wagner; Jeff D Williamson; Joseph A Maldjian; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2015-09-25       Impact factor: 2.852

2.  Genetic analysis of advanced glycation end products in the DHS MIND study.

Authors:  Jeremy N Adams; Laura M Raffield; Susan E Martelle; Barry I Freedman; Carl D Langefeld; J Jeffrey Carr; Amanda J Cox; Donald W Bowden
Journal:  Gene       Date:  2016-02-23       Impact factor: 3.688

3.  Heritability of cognitive traits among siblings with a parental history of Alzheimer's disease.

Authors:  Burcu F Darst; Rebecca L Koscik; Bruce P Hermann; Asenath La Rue; Mark A Sager; Sterling C Johnson; Corinne D Engelman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Heritability and genetic association analysis of neuroimaging measures in the Diabetes Heart Study.

Authors:  Laura M Raffield; Amanda J Cox; Christina E Hugenschmidt; Barry I Freedman; Carl D Langefeld; Jeff D Williamson; Fang-Chi Hsu; Joseph A Maldjian; Donald W Bowden
Journal:  Neurobiol Aging       Date:  2014-11-20       Impact factor: 4.673

5.  Analysis of the relationships between type 2 diabetes status, glycemic control, and neuroimaging measures in the Diabetes Heart Study Mind.

Authors:  Laura M Raffield; Amanda J Cox; Barry I Freedman; Christina E Hugenschmidt; Fang-Chi Hsu; Benjamin C Wagner; Jianzhao Xu; Joseph A Maldjian; Donald W Bowden
Journal:  Acta Diabetol       Date:  2015-11-02       Impact factor: 4.280

6.  Neuroimaging endophenotypes of type 2 diabetes mellitus: a discordant sibling pair study.

Authors:  Dong Zhang; Lin Shi; Xiubao Song; Changzheng Shi; Pan Sun; Wutao Lou; Defeng Wang; Liangping Luo
Journal:  Quant Imaging Med Surg       Date:  2019-06

7.  Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint study.

Authors:  Mingzhe Zhao; Jingsong Ma; Mo Li; Wenli Zhu; Wei Zhou; Lu Shen; Hao Wu; Na Zhang; Shaochang Wu; Chunpeng Fu; Xianxi Li; Ke Yang; Tiancheng Tang; Ruoxi Shen; Lin He; Cong Huai; Shengying Qin
Journal:  Transl Psychiatry       Date:  2022-04-28       Impact factor: 7.989

8.  Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Masashi Ikeda; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Satomi Umeda-Yano; Masaki Fukunaga; Haruo Fujino; Yoshiyuki Watanabe; Masao Iwase; Hiroaki Kazui; Nakao Iwata; Daniel R Weinberger; Masatoshi Takeda
Journal:  Schizophr Bull       Date:  2014-12-22       Impact factor: 9.306

9.  Genetic effects and gene-by-education interactions on episodic memory performance and decline in an aging population.

Authors:  Jennifer A Smith; Minjung Kho; Wei Zhao; Miao Yu; Colter Mitchell; Jessica D Faul
Journal:  Soc Sci Med       Date:  2018-11-10       Impact factor: 4.634

10.  Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.

Authors:  Rongrong Cai; Jing Han; Jie Sun; Rong Huang; Sai Tian; Yanjue Shen; Xue Dong; Wenqing Xia; Shaohua Wang
Journal:  Front Aging Neurosci       Date:  2016-07-28       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.